Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $60,700,210 |
Sells | 129 | $20,005,523 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
25 Aug 2023 16:57 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 24 Aug 2023 | Sale | 1 | 20.89 | 21 | D |
25 Aug 2023 16:57 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 24 Aug 2023 | Sale | 12,332 | 20.3 | 250,340 | D |
16 Aug 2023 16:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 14 Aug 2023 | Sale | 11,314 | 22.04 | 249,361 | D |
16 Aug 2023 16:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 14 Aug 2023 | Sale | 91,744 | 21.34 | 1,957,817 | D |
08 Aug 2023 16:44 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 07 Aug 2023 | Sale | 101,339 | 21.73 | 2,202,096 | D |
27 Jul 2023 16:33 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 26 Jul 2023 | Sale | 3,917 | 21.63 | 84,725 | D |
20 Jul 2023 16:37 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 19 Jul 2023 | Sale | 426 | 24.94 | 10,624 | D |
20 Jul 2023 16:35 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 19 Jul 2023 | Sale | 2,725 | 24.94 | 67,962 | D |
13 Jul 2023 17:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,233 | 19.73 | 63,787 | D |
13 Jul 2023 17:10 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 12 Jul 2023 | Sale | 1,470 | 19.73 | 29,003 | D |
26 Apr 2023 16:12 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 25 Apr 2023 | Sale | 509 | 16.29 | 8,292 | D |
26 Apr 2023 16:08 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 25 Apr 2023 | Sale | 2,633 | 16.29 | 42,892 | D |
19 Apr 2023 16:15 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 18 Apr 2023 | Sale | 3,423 | 15.27 | 52,269 | D |
19 Apr 2023 16:12 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 18 Apr 2023 | Sale | 1,544 | 15.27 | 23,577 | D |
19 Apr 2023 16:09 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 18 Apr 2023 | Sale | 3,395 | 15.27 | 51,842 | D |
03 Feb 2023 07:24 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 02 Feb 2023 | Sale | 537 | 18.24 | 9,795 | D |
27 Jan 2023 07:20 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 26 Jan 2023 | Sale | 10,156 | 18.51 | 187,988 | D |
13 Jan 2023 08:21 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 11 Jan 2023 | Sale | 4,021 | 16.8 | 67,553 | D |
13 Jan 2023 08:19 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Dev. & Tech. Officer | 11 Jan 2023 | Sale | 60,471 | 16.79 | 1,015,308 | D |
13 Jan 2023 08:19 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Dev. & Tech. Officer | 11 Jan 2023 | Sale | 19 | 15.16 | 288 | D |
13 Jan 2023 08:16 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 11 Jan 2023 | Sale | 4,499 | 16.75 | 75,358 | D |
13 Jan 2023 08:16 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 11 Jan 2023 | Sale | 11 | 15.15 | 167 | D |
13 Jan 2023 08:13 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 11 Jan 2023 | Sale | 44,448 | 16.75 | 744,504 | D |
13 Jan 2023 08:13 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 11 Jan 2023 | Sale | 120 | 15.11 | 1,813 | D |
25 Oct 2022 07:43 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 21 Oct 2022 | Sale | 341 | 9.67 | 3,297 | D |
17 Oct 2022 08:59 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Dev. & Tech. Officer | 13 Oct 2022 | Sale | 928 | 9.18 | 8,519 | D |
17 Oct 2022 08:57 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 13 Oct 2022 | Sale | 2,793 | 9.18 | 25,640 | D |
13 Oct 2022 16:20 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 11 Oct 2022 | Sale | 12,500 | 9.44 | 118,000 | D |
07 Oct 2022 16:32 | IMVT | Immunovant Inc | ROIVANT SCIENCES LTD. | 10% | 06 Oct 2022 | Purchase | 416,667 | 6 | 2,500,002 | D |
04 Oct 2022 16:27 | IMVT | Immunovant Inc | PANDE ATUL | Director | 30 Sep 2022 | Purchase | 15,000 | 5.6 | 84,000 | I |
29 Sep 2022 17:09 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Dev. & Tech. Officer | 28 Sep 2022 | Sale | 535 | 4.67 | 2,498 | D |
29 Sep 2022 17:06 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 28 Sep 2022 | Sale | 1,605 | 4.67 | 7,495 | D |
29 Sep 2022 16:21 | IMVT | Immunovant Inc | TORTI FRANK | Director | 29 Sep 2022 | Purchase | 20,000 | 5.81 | 116,200 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)